±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 996  |  »Ø¸´: 15
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

yalefield

½ð³æ (ÎÄ̳¾«Ó¢)

ÀϺºÒ»Ã¶

[½»Á÷] FDA QSAR Toxicity Models Now Available

http://www.leadscope.com/fda_qsar_models/

Columbus, Ohio August 26, 2008 ¨C Leadscope announces the availability of the Leadscope FDA QSAR Toxicity Models.  

Leadscope is making the FDA QSAR Toxicity Models available through a Cooperative Research & Development Agreement with the U.S. Food & Drug Administration (FDA). These models allow scientists to predict the potential toxicity and adverse human clinical effects of pharmaceuticals, cosmetics, food ingredients and other chemicals.

The Models are constructed by FDA scientists based on both proprietary and non-proprietary data. Leadscope technology allows delivery of models without disclosing any training sets.

The FDA QSAR Toxicity Models will be distributed via annual licenses in Suites containing multiple models relative to specific biological endpoints.  The following Suites are now available:

Toxicity Endpoints                                                        Human Clinical Endpoints
▪ Rodent Carcinogenicity                                              ▪ Cardiological Adverse Effects
▪ Genetic Toxicity                                                         ▪ Hepatobiliary Adverse Effects
▪ Reproductive Toxicity                                                ▪ Urinary Tract Adverse Effects
▪ Developmental Toxicity
▪ Neurotoxicity
▪ Misc. Toxicity Endpoints

A scientist may enter a single compound or a batch of compounds and receive predictions across multiple endpoints.  The FDA QSAR Toxicity Models are a stand-alone product not requiring any other software or training.

Loftus Lucas, Leadscope¡¯s CEO, said, ¡°The release of these FDA QSAR Toxicity Models culminates several years of work with the FDA to bring their toxicity data to scientists in an easy to use system.  Scientists will get the same prediction from these Models as an FDA Regulator¡±.  

The FDA Center for Drug Evaluation and Research (CDER) Informatics and Computational Safety Analysis Staff (ICSAS) and Leadscope are pleased to host a symposium on the use of Leadscope software with FDA databases for QSAR computational toxicology safety analysis at the FDA, other U.S. government agencies and international regulatory bodies.  The all-day meeting will be held on September 17, 2008 at the new FDA White Oak Campus in Silver Spring, Maryland.  This symposium is free and open to the public.  To view the agenda visit www.leadscope.com/fda_symposium.php.  Registration is required.  Please RSVP by September 12, 2008, at info@leadscope.com.  

To view the FDA QSAR Model Suites visit Leadscope¡¯s website at www.leadscope.com/fda_qsar_models.  For further information or to request on-line demonstration with a Leadscope scientist, contact us at info@leadscope.com.

Loftus Lucas
Leadscope, Inc.

1393 Dublin Road
Columbus, Ohio 43215
Phone: 614-599-2700
Fax:  614-675-3732

info@leadscope.com
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

tjegg

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

ÒýÓûØÌû:
Originally posted by yalefield at 2008-8-28 17:13:
UCSDÄǼһïÊDz»ÊÇ˵һ±²×Ó¶¼²»À뿪San Diego£¿

²»»á°É£¬Ëû»¹¿¼ÂÇÏë»Ø¹ú·¢Õ¹ÄØ£¬Ä¿Ç°ÔÚ×öÉúÎïÐÅÏ¢¡£
³ýÁËÄãµÄÇ×ÈË£¬Ã»ÓÐÈËÓ¦¸Ã¶ÔÄãºÃ£¬¶ÔÄãºÃµÄÈË£¬Ò»¶¨ÒªÕäϧ¡£
7Â¥2008-08-29 07:37:17
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 16 ¸ö»Ø´ð

dnp

ÈÙÓþ°æÖ÷ (ÖªÃû×÷¼Ò)

Сľ³æÀË×Ó

ÓÅÐã°æÖ÷

ºÇºÇ£¬»¯Ñ§¼ÆÁ¿Ñ§Èí¼þ¹úÍâ·¢Õ¹µÃÔ½À´Ô½ºÃÁË£¬µ«ÊǹúÄÚÈ´ÓеãÌá²»ÉÏÆø¹þ~~
What would Jesus do?
2Â¥2008-08-27 11:46:30
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

tjegg

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

ºÃ¶«Î÷£¬Ð»Ð»Â§×¡¡£
³ýÁËÄãµÄÇ×ÈË£¬Ã»ÓÐÈËÓ¦¸Ã¶ÔÄãºÃ£¬¶ÔÄãºÃµÄÈË£¬Ò»¶¨ÒªÕäϧ¡£
3Â¥2008-08-27 21:08:00
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

yalefield

½ð³æ (ÎÄ̳¾«Ó¢)

ÀϺºÒ»Ã¶

ÒýÓûØÌû:
Originally posted by tjegg at 2008-8-27 21:08:
ºÃ¶«Î÷£¬Ð»Ð»Â§×¡¡£

Ì«ÈÈ£¬²»Â§ÁË¡£
4Â¥2008-08-27 22:08:08
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] Çóµ÷¼Á£¬Ò»Ö¾Ô¸±±¾©ÖÐÒ½Ò©´óѧ +3 СС´ï²»Áï 2026-04-02 3/150 2026-04-03 22:55 by ³åʸêÄÐÇÍÅ
[¿¼ÑÐ] Çóµ÷¼Á +3 wos666 2026-04-03 3/150 2026-04-03 21:36 by lbsjt
[¿¼ÑÐ] 283·ÖÇóµ÷¼Á +6 СÄô°®Ñ§Ï° 2026-04-03 6/300 2026-04-03 20:46 by zhq0425
[¿¼ÑÐ] 0856£¬269·ÖÇóµ÷¼Á +15 ÓÐѧÉϾÍÐÐÇóÇóÁ 2026-03-30 18/900 2026-04-03 16:50 by melodiousnow
[¿¼ÑÐ] ²ÄÁÏר˶µ÷¼Á +18 Ò¬Ò¬¡£ 2026-03-29 18/900 2026-04-03 16:45 by ÁáÁá0606
[¿¼ÑÐ] 334Çóµ÷¼Á +9 Trying] 2026-03-31 9/450 2026-04-03 15:18 by ×ÁçíØ¼
[¿¼ÑÐ] ÖØÇì´óѧ²ÄÁÏÓ뻯¹¤085600£¬³õÊÔ370+£¬ÇóÇóµ÷¼Á½¨Òé +8 shzhou_ 2026-04-01 9/450 2026-04-03 09:31 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 295Çóµ÷¼Á +7 Ô¸ÂÃ;ÓÀԶ̹Ȼ 2026-04-02 7/350 2026-04-03 08:22 by fangshan711
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +8 ÀÁÑòÑòÇáÖÃÓñÍÎ 2026-04-02 8/400 2026-04-02 22:03 by liu823948201
[¿¼ÑÐ] 085602 ÕÒµ÷¼Á +3 ÄæÊ±Õë¿ìÀÖ 2026-04-02 3/150 2026-04-02 21:23 by dongzh2009
[¿¼ÑÐ] ¡¾Çóµ÷¼Á¡¿ÐÂÄÜÔ´²ÄÁϱ¾¿Æ£¬Ò»Ö¾Ô¸211£¬³õÊÔ321 +6 Çóµ÷¼ÁѧУ£¬ 2026-04-02 6/300 2026-04-02 09:41 by Çç¿Õ210210
[¿¼ÑÐ] 11408 321·ÖÇóµ÷¼Á +3 huchun12138 2026-03-30 4/200 2026-04-01 22:48 by guanxin1001
[¿¼ÑÐ] 379Çóµ÷¼Á +3 ?¿à¹Ï²»¿à 2026-04-01 3/150 2026-04-01 20:09 by ÄºÔÆÇ庮
[¿¼ÑÐ] 0855»úе³õÊÔ280Çóµ÷¼Á +3 kazenotori 2026-03-31 3/150 2026-04-01 10:08 by JourneyLucky
[¿¼ÑÐ] 289Çóµ÷¼Á +7 BrightLL 2026-03-29 7/350 2026-03-31 22:05 by 544594351
[¿¼ÑÐ] Ò»Ö¾Ô¸Äϲý´óѧ324Çóµ÷¼Á +6 hanamiko 2026-03-29 6/300 2026-03-31 16:35 by hypershenger
[¿¼ÑÐ] ±¾¿Æ211ÉúÎïҽѧ¹¤³Ì085409Çóµ÷¼Á339·Ö +7 Àï×Óľyy 2026-03-29 7/350 2026-03-31 14:35 by fmesaito
[¿¼ÑÐ] 085404 22408 315·Ö +5 zhuangyan123 2026-03-31 6/300 2026-03-31 13:48 by limeifeng
[¿¼ÑÐ] 262Çóµ÷¼Á +7 ZZ..000 2026-03-30 8/400 2026-03-31 10:05 by cal0306
[¿¼ÑÐ] һ־ԸʳƷ¿ÆÑ§Ó빤³Ì083200Çóµ÷¼Á +4 XQTJZ 2026-03-30 4/200 2026-03-31 04:10 by fmesaito
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û